@JZarkaMD @Anand_88_Patel @garciamanero @Dr_AmerZeidan @ASCO @OncoAlert @UChicagoMed @YaleCancer @MDAndersonNews For the question of meaningful transfusion independence duration perhaps the TWiTR approach is best https://t.co/UcKIUp7aDY @MikkaelSekeres …
ICYMI: Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes https://t.co/n1t4y9zQpY
RT @LeukDocJZ: Excited to share our new paper in @Haematologica- Time Without Transfusion Reliance (TWiTR)- a new assessment tool for eval.…
RT @LeukDocJZ: Excited to share our new paper in @Haematologica- Time Without Transfusion Reliance (TWiTR)- a new assessment tool for eval.…